Browse Tag


Scientists explain why Uranus and Neptune are different colours

1 min read

The FINANCIAL — Neptune and Uranus have much in common – they have similar masses, sizes, and atmospheric compositions – yet Neptune looks distinctly bluer than its planetary neighbour Uranus.…


Rainforest trees may have been dying faster since the 1980s

2 mins read

The FINANCIAL — Tropical trees in Australia’s rainforests have been dying at double the previous rate since the 1980s, seemingly because of climate impacts, according to the findings of a long-term international study published in Nature today. This research has found the death rates of tropical trees have doubled in the last 35 years, as…

Anti-cancer drug derived from fungus shows promise in clinical trials

2 mins read

The FINANCIAL — A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.…

Vaccines still effective against Delta variant of concern, Oxford study

3 mins read

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant of concern dominant in the UK today, according to a study from the University of Oxford.…

Elephants show risk-avoidance behaviour in response to human-generated seismic cues

3 mins read

The FINANCIAL -- Researchers at the University of Oxford and Save the Elephants have found evidence that African elephants (Loxodonta africana) listen and react to ground vibrations created by human activity.…

Profiling by powerful tech firms risks undermining consumer choice

2 mins read

The FINANCIAL --  Behavioural targeting online by dominant ad-tech businesses risks the welfare of consumers, requiring stricter enforcement of current laws, according to new research from experts in ethics and law from the Oxford Internet Institute.…

Human challenge trial launches to study immune response to COVID-19

3 mins read

The FINANCIAL -- Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time, Oxford University notes.…

Oxford COVID-19 vaccine trial pauses after volunteer falls ill

3 mins read

The FINANCIAL — The outcome of vaccine trials is being closely watched around the world. Pharmaceutical company AstaZeneca said Tuesday that it had paused global trials of its coronavirus vaccine in America as it is investigating one of the volunteers in United Kingdom who had a serious side effect – unexplained illness. It’s a standard precaution…